Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This clinical trial studies whether continuous glucose monitoring (CGM) can be used to help patients with glioblastoma manage their blood sugar (glucose) levels and improve survival. Glioblastoma is the most common malignant primary brain tumor in adults, with an average survival time of approximately 15-18 months despite therapy. Studies have shown that having a higher-than-normal amount of glucose in the blood (hyperglycemia) during radiation therapy is associated with poorer survival outcomes in glioblastoma patients. Hyperglycemia in glioblastoma patients is often driven by steroids that are commonly used during treatment. CGM uses a device that places a sensor under the skin that monitors glucose levels at regular intervals, providing real-time, or near real-time, glucose information. This can help to identify when a patient has changes in their glucose levels so they may receive necessary interventions or medications sooner. CGM may be an effective way for glioblastoma patients to manage their glucose levels, which may improve survival.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Nowo zdiagnozowany glejąk potwierdzona badaniem MRI mózgu
- •Wiek co najmniej 18 lat
- •Dobry stan ogólny (skala Karnofskiego co najmniej 70 punktów)
- •Wystarczająca liczba białych i czerwonych krwinek oraz płytek krwi
- •Prawidłowe funkcje nerek (kreatynina w normie lub prześwit kreatyninowy ≥60)
- •Prawidłowe funkcje wątroby
- •Gotowość do używania urządzenia monitorującego i udziału w poradach dietetycznych
✗ Disqualifies
- •Powracający glejąk
- •Zaburzenia odżywiania (anoreksja, bulimia) lub uzależnienia w ciągu ostatnich 12 miesięcy
- •Niekontrolowane poważne problemy zdrowotne (serca, wątroby, nerek, psychiatryczne)
- •Inny aktywny nowotwór wymagający leczenia
- •Ciąża lub karmienie piersią
- •Cukrzyca typu 1
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 17, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (3)
Mayo Clinic in Arizona
Phoenix, United States
Mayo Clinic in Florida
Jacksonville, United States
Mayo Clinic in Rochester
Rochester, United States
Trial contact
Clinical Trials Referral Office
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/5/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.